biospace med Expands U.S. Market Penetration with ‘EOS’, Which Cuts Radiation up to 90% vs. Conventional X-Rays

CAMBRIDGE, Mass. & PARIS--(BUSINESS WIRE)--Biospace med announced today that it continues to penetrate the U.S. market with its FDA-cleared ‘EOS’ x-ray imager—the world’s first ultra-low-dose x-ray technology—recently adding new customers in the Midwest and Southeast regions of the United States. In addition, Professor Georges Charpak, inventor of the EOS technology, has received the ‘Centenary Medal’ from the French Radiological Society (SFR), the esteemed organization’s highest honor.

MORE ON THIS TOPIC